Hepatitis C in Iceland: a milestone for global elimination.
| Autor: | Dalgard O; Department of Infectious Diseases, Akershus University Hospital, 1478 Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: odalgard@medisin.uio.no., Midgard H; Department of Infectious Diseases, Akershus University Hospital, 1478 Lørenskog, Norway., Kielland KB; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital, Brumundal, Norway. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Aug; Vol. 6 (8), pp. 599-600. Date of Electronic Publication: 2021 Jun 23. |
| DOI: | 10.1016/S2468-1253(21)00182-5 |
| Abstrakt: | Competing Interests: OD received grants from Gilead, AbbVie, and Merck Sharp & Dohme. HM received personal fees for participation in advisory board for Gilead, AbbVie, and Merck Sharp & Dohme. KBK declares no competing interests. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|